Variables | Control group n = 82 | POCUS group n = 83 | P value |
---|---|---|---|
Men | 48 (59) | 55 (66) | 0.31 |
Age, median [IQR] years | 67 [57–77] | 70 [59–81] | 0.49 |
Indication for placing the call to the RRTs | Â | Â | Â |
Respiratory | 56 (68) | 61 (74) | 0.46 |
Circulatory | 26 (32) | 22 (26) | Â |
Indication for hospital admission | Â | Â | Â |
Cardiac | 10 (12) | 3 (4) | 0.27 |
Respiratory | 30 (37) | 23 (28) | Â |
Neurologic | 2 (2) | 7 (9) | Â |
Digestive | 8 (10) | 8 (10) | Â |
Obstetrical | 1 (1,5) | 0 | Â |
Infectious | 2 (2,5) | 2 (2) | Â |
General | 4 (5) | 4 (5) | Â |
Surgery | 24 (29) | 28 (34) | Â |
Urologic | 0 | 2 (2) | Â |
Vascular | 1 (1) | 3 (4) | Â |
Traumatic | 0 | 3 (4) | Â |
BMI (> 25), kg/m2 |  |  |  |
 | 41 (50) | 39 (47) | 0.70 |
ASA score | Â | Â | Â |
I-II | 23 (28) | 23 (28) | 0.99 |
III | 47 (57) | 48 (58) | Â |
IV–V | 12 (15) | 12 (14) |  |
SAPS IIb, median [IQR] | Â | Â | Â |
 | 46 [34–57] | 40 [33–52] | 0.51 |
Comorbidities | Â | Â | Â |
Allergy | 9 (11) | 8 (10) | 0.78 |
Coronary disease | 22 (27) | 23 (28) | 0.89 |
Heart failure | 19 (23) | 27 (32) | 0.18 |
Chronic kidney disease | 11 (13) | 19 (22) | 0.16 |
Cancer | 28 (34) | 26 (31) | 0.70 |
Immunodepression | 10 (12) | 13 (15) | 0.52 |
Dementia | 5 (6) | 3 (4) | 0.49 |
Stroke | 8 (9,8) | 9 (11) | 0.82 |
Epilepsy | 5 (6) | 1 (1) | 0.12 |
Diabetes | 13 (16) | 21 (25) | 0.13 |
Liver disease | 6 (7) | 6 (7) | 0.98 |
COPD | 36 (44) | 30 (36) | 0.31 |
Habitual smoker | 42 (51) | 34 (41) | 0.19 |
Definitive diagnosisc | Â | Â | Â |
Exacerbation of asthma | 3 (5) | 3 (5) | 0.60 |
Septic shock | 14 (17) | Â | 14 (17) |
Pneumonia | 18 (22) | 7 (8) | Â |
Cardiogenic edema | 10 (12) | 13 (16) | Â |
Hemorrhagic shock | 7 (8) | 4 (5) | Â |
Atelectasis | 1 (1) | 4 (5) | Â |
Exacerbation of COPD | 5 (6) | 6 (7) | Â |
Pneumothorax | 1 (1) | 1 (1) | Â |
Pleural effusion | 3 (5) | 4 (5) | Â |
Acute interstitial lung disease (non-cardiogenic edema) | 4 (5) | 7 (8) | Â |
Pulmonary embolism | 2 (2) | 2 (2) | Â |
Cardiogenic shock | 2 (2) | 2 (2) | Â |
Hypovolemic shock | 1 (1) | 1 (1) | Â |
Tamponade | 1 (1) | 2 (2) | Â |
Exacerbation of COPD/cardiogenic edema | 0 | 1 (1) | Â |
Pneumonia/cardiogenic edema | 0 | 1 (1) | Â |
Pneumonia/acute interstitial lung disease (non-cardiogenic edema) | 1 (1) | 3 (5) | Â |
Exacerbation of COPD/pneumothorax | 2 (2) | 0 | Â |
Normal | 0 | 2 (2) | Â |
Other†| 7 (9) | 6 (8) |  |
Urine volume 24Â h before inclusion (ml/day) | Â | Â | Â |
 < 200 | 6 (7) | 4 (5) | 0.58 |
 < 500 | 29 (35) | 24 (29) |  |
 > 500 | 37 (45) | 40 (48) |  |
 > 1000 | 10 (12) | 15 (18) |  |
Mottlingd | 22 (27) | 10 (12) | 0.02 |
Respiratory distress syndrome | 49 (60) | 54 (65) | 0.48 |
Abnormal chest auscultatione | 62 (76) | 59 (71) | 0.51 |
Thorax X-ray < 24 h | 35 (42) | 38 (46) | 0.69 |
MAP, median [IQR], mmHg | 82 [70–100] | 93 [72–113] | 0.02 |
Heart rate, median [IQR], bpm* | 100 [80–120] | 107 [85–130] | 0.46 |
Serum lactate median [IQR], mmol/l | 2 [1–3] | 2 [1–3] | 0.95 |
Hemoglobin, median [IQR], g/dl | 11 [9–13] | 11 [9–12] | 0.18 |
Serum creatinine, median [IQR],mmol/L | 79 [52–125] | 82 [62 -132] | 0.51 |
Total bilirubin, median [IQR] umol/l | 10 [8–16] | 10 [8–16] | 0.91 |
Serum potassium, median [IQR], mmol/L | 4 [4, 5] | 4 [4, 5] | 0.41 |
Volemic expansion at the bedside, median [IQR], ml/kg | 3 [0–10] | 4 [0 -12] | 0.73 |
Respiratory rate, median [IQR] bpm** | 27 [20–35] | 25 [20–35] | 0.51 |
SpO2, median [IQR], % | 92 [89–96] | 94 [90–97] | 0.16 |
PaO2/FiO2 ratio, median [IQR] | 186 [121–284] | 203 [136–355] | 0.28 |
Glasgow score, median [IQR] | 15 [2–15] | 15 [14, 15] | 0.08 |
BNP, median [IQR] pg/ml | 306 [129–584] | 188 [62–833] | 0.61 |
Oxygen rate flow, median [IQR], L/min | 12 [5–15] | 6 [2–15] | 0.003 |
Orientation after inclusion | Â | Â | Â |
Immediate ICU | 59 (72) | 49 (55) | 0.15 |
Operative room | 5 (6) | 7 (8) | Â |
Emergency room | 4 (5) | 9 (12) | Â |
Ward | 14 (17) | 21 (25) | Â |